Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 8;13(10):2023.
doi: 10.3390/life13102023.

The Gut-Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics

Affiliations
Review

The Gut-Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics

Georgia Saxami et al. Life (Basel). .

Abstract

The human gut microbiota (GM) is a complex microbial ecosystem that colonises the gastrointestinal tract (GIT) and is comprised of bacteria, viruses, fungi, and protozoa. The GM has a symbiotic relationship with its host that is fundamental for body homeostasis. The GM is not limited to the scope of the GIT, but there are bidirectional interactions between the GM and other organs, highlighting the concept of the "gut-organ axis". Any deviation from the normal composition of the GM, termed "microbial dysbiosis", is implicated in the pathogenesis of various diseases. Only a few studies have demonstrated a relationship between GM modifications and disease phenotypes, and it is still unknown whether an altered GM contributes to a disease or simply reflects its status. Restoration of the GM with probiotics and prebiotics has been postulated, but evidence for the effects of prebiotics is limited. Prebiotics are substrates that are "selectively utilized by host microorganisms, conferring a health benefit". This study highlights the bidirectional relationship between the gut and vital human organs and demonstrates the relationship between GM dysbiosis and the emergence of certain representative diseases. Finally, this article focuses on the potential of prebiotics as a target therapy to manipulate the GM and presents the gaps in the literature and research.

Keywords: gut microbiota dysbiosis; gut–organ axis; prebiotics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic diagram depicting the influence of GM dysbiosis on the gut–organ axis. GM dysbiosis leads to the degradation of mucin, disrupts the gut’s protective barrier, increases its permeability, and enables pathogenic microorganisms, along with their by-products and endotoxins, to infiltrate. This invasion results in the activation of immune cells and triggers systemic inflammation through the peripheral circulation. The impact of GM dysbiosis extends beyond the gastrointestinal tract. Recent research indicates two-way interactions between the GM and various organs, emphasizing the idea of a “gut–organ axis”. This communication is facilitated through a range of signalling pathways and direct interactions between the host and the GM. Arrows indicate a bidirectional relationship between the gut and each organ. Parts of the figure were drawn using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/ accessed on 25 August 2023).

References

    1. Hou K., Wu Z.-X., Chen X.-Y., Wang J.-Q., Zhang D., Xiao C., Zhu D., Koya J.B., Wei L., Li J., et al. Microbiota in health and diseases. Signal Transduct. Target. Ther. 2022;7:135. doi: 10.1038/s41392-022-00974-4. - DOI - PMC - PubMed
    1. Chen Y., Zhou J., Wang L. Role and mechanism of gut microbiota in human disease. Front. Cell. Infect. Microbiol. 2021;11:86 - PMC - PubMed
    1. Afzaal M., Saeed F., Shah Y.A., Hussain M., Rabail R., Socol C.T., Hassoun A., Pateiro M., Lorenzo J.M., Rusu A.V. Human gut microbiota in health and disease: Unveiling the relationship. Front. Microbiol. 2022;13:999001. - PMC - PubMed
    1. Sender R., Fuchs S., Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14:e1002533. - PMC - PubMed
    1. Matzaras R., Nikopoulou A., Protonotariou E., Christaki E. Gut microbiota modulation and prevention of dysbiosis as an alternative approach to antimicrobial resistance: A narrative review. Yale J. Biol. Med. 2022;95:479. - PMC - PubMed

LinkOut - more resources